Gatekeepers of ovarian fate: the molecular landscape of diminished ovarian reserve
- 1State Key Laboratory of Female Fertility Promotion, Department of Traditional Chinese Medicine, Peking University Third Hospital
- 2Department of Traditional Chinese Medicine, Peking University People’s Hospital
- 3Department of Integrated Traditional Chinese and Western Medicine, Peking University First Hospital
Abstract
Diminished ovarian reserve (DOR) is a major reproductive disorder characterised by accelerated follicular depletion and impaired ovarian responsiveness, yet its molecular basis remains incompletely understood. This review integrates current evidence across the major biological processes that determine ovarian reserve and follicular competence. Primordial follicle activation governed by PI3K–AKT–FOXO3/PTEN–mTOR, Hippo–YAP, KIT/KITL and AMH signaling represents an upstream determinant of follicle-pool consumption, while bidirectional oocyte–granulosa cell communication and the stromal microenvironment sustain follicular development. Genomic instability, defective DNA repair, chromatin remodeling and epigenetic dysregulation further compromise cellular integrity and reproductive longevity. Mitochondrial bioenergetic failure, mtDNA instability, altered mitochondrial dynamics and oxidative stress form a central mechanistic hub linking metabolic dysfunction to follicular damage. Emerging evidence additionally highlights the autophagy–mitophagy–lysosome system, including stress-granule clearance and lysosomal proteostasis, as a context-dependent quality-control network rather than an intrinsically lethal pathway. Downstream cell-fate responses, particularly granulosa-cell apoptosis, cellular senescence and ferroptosis, together with immune–inflammatory and endocrine disturbances, further promote follicular attrition. Importantly, the strength of evidence varies substantially across mechanisms, with direct human DOR data available for only a subset of pathways and many proposed mechanisms remaining dependent on animal or cellular models. Clinically, AMH and antral follicle count remain the principal reserve markers, whereas molecular biomarkers and targeted interventions are largely investigational. By organizing these mechanisms into an integrated framework, this review identifies key evidence gaps and priorities for mechanistically informed biomarker development and therapeutic translation in DOR.
Related
- Pretreatment AMH–AFC stratification of poor-ovarian-response risk in young women with diminished ovarian reserve: a multicentre retrospective cohort study
- Is the Benefit of High-Potency Progestins for Endometrial Hyperplasia Specific to Diminished Ovarian Reserve? [Letter]
- Macrophages and immunometabolism in diminished ovarian reserve: pathological features and therapeutic implications.
- Serum miRNA expression profile in responders to acupuncture treatment for diminished ovarian reserve: a study protocol for a nested case-control study.
- Yijing Decoction improves oocyte quality and inhibits lactate accumulation in mice with diminished ovarian reserve
BibTeX
@article{tang2026gatekeepers,
title = {{Gatekeepers of ovarian fate: the molecular landscape of diminished ovarian reserve}},
author = {Li Tang and Long Zhou and Guanghui Cui and Jiacheng Zhang and Hangqi Hu and Ruifan Lin and Yuxin Jin and Ze Ma and Xichen Chai and Lan Wang and Yutian Zhu and Xiyan Xin and Yang Ye and Dong Li},
journal = {Frontiers in Endocrinology},
year = {2026},
month = oct,
doi = {10.3389/fendo.2026.1926422},
url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.1926422/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Gatekeepers of ovarian fate: the molecular landscape of diminished ovarian reserve
AU - Li Tang
AU - Long Zhou
AU - Guanghui Cui
AU - Jiacheng Zhang
AU - Hangqi Hu
AU - Ruifan Lin
AU - Yuxin Jin
AU - Ze Ma
AU - Xichen Chai
AU - Lan Wang
AU - Yutian Zhu
AU - Xiyan Xin
AU - Yang Ye
AU - Dong Li
PY - 2026
DA - 2026/10/26
JO - Frontiers in Endocrinology
DO - 10.3389/fendo.2026.1926422
UR - https://www.frontiersin.org/articles/10.3389/fendo.2026.1926422/full
AB - Diminished ovarian reserve (DOR) is a major reproductive disorder characterised by accelerated follicular depletion and impaired ovarian responsiveness, yet its molecular basis remains incompletely understood. This review integrates current evidence across the major biological processes that determine ovarian reserve and follicular competence. Primordial follicle activation governed by PI3K–AKT–FOXO3/PTEN–mTOR, Hippo–YAP, KIT/KITL and AMH signaling represents an upstream determinant of follicle-pool consumption, while bidirectional oocyte–granulosa cell communication and the stromal microenvironment sustain follicular development. Genomic instability, defective DNA repair, chromatin remodeling and epigenetic dysregulation further compromise cellular integrity and reproductive longevity. Mitochondrial bioenergetic failure, mtDNA instability, altered mitochondrial dynamics and oxidative stress form a central mechanistic hub linking metabolic dysfunction to follicular damage. Emerging evidence additionally highlights the autophagy–mitophagy–lysosome system, including stress-granule clearance and lysosomal proteostasis, as a context-dependent quality-control network rather than an intrinsically lethal pathway. Downstream cell-fate responses, particularly granulosa-cell apoptosis, cellular senescence and ferroptosis, together with immune–inflammatory and endocrine disturbances, further promote follicular attrition. Importantly, the strength of evidence varies substantially across mechanisms, with direct human DOR data available for only a subset of pathways and many proposed mechanisms remaining dependent on animal or cellular models. Clinically, AMH and antral follicle count remain the principal reserve markers, whereas molecular biomarkers and targeted interventions are largely investigational. By organizing these mechanisms into an integrated framework, this review identifies key evidence gaps and priorities for mechanistically informed biomarker development and therapeutic translation in DOR.
SN - 1664-2392
ER -